Entocort EC (budesonide) is a Crohn's disease treatment for mild to moderate disease involving the ileum and/or the ascending colon. Entocort EC is a non-systemic glucocorticosteroid that is released ...

LONDON, May 18 (Reuters) - AstraZeneca has settled a U.S. patent dispute with Teva Pharmaceuticals by allowing Teva to sell a generic version of Astra's Entocort EC drug for Crohn's disease from 2012.

Agreement follows ex-US divestment of Entocort in July 2015 23 November 2015 - AstraZeneca today announced that it has entered into an agreement with Perrigo Company plc for the divestment of US ...